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ABSTRACT We have determined directly the effects of the inhibitory peptide phospholamban (PLB) on the rotational dynamics
of the calcium pump (Ca-ATPase) of cardiac sarcoplasmic reticulum (SR). This was accomplished by comparing mouse ven-
tricular SR, which has PLB levels similar to those found in other mammals, with mouse atrial SR, which is effectively devoid
of PLB and thus has much higher (unregulated) calcium pump activity. To obtain sufficient quantities of atrial SR, we isolated
the membranes from atrial tumor cells. We used time-resolved phosphorescence anisotropy of an erythrosin isothiocyanate label
attached selectively and rigidly to the Ca-ATPase, to detect the microsecond rotational motion of the Ca-ATPase in the two
preparations. The time-resolved phosphorescence anisotropy decays of both preparations at 250C were multi-exponential,
because of the presence of different oligomeric species. The rotational correlation times for the different oligomers were similar
for the two preparations, but the total decay amplitude was substantially greater for atrial tumor SR, indicating that a smaller
fraction of the Ca-ATPase molecules exists as large aggregates. Phosphorylation of PLB in ventricular SR decreased the
population of large-scale Ca-ATPase aggregates to a level similar to that of atrial tumor SR. Lipid chain mobility (fluidity), detected
by electron paramagnetic resonance of stearic acid spin labels, was very similar in the two preparations, indicating that the higher
protein mobility in atrial tumor SR is not due to higher lipid fluidity. We conclude that PLB inhibits by inducing Ca-ATPase lateral
aggregation, which can be relieved either by phosphorylating or removing PLB.
INTRODUCTION
The Ca-ATPase of the sarcoplasmic reticulum (SR) is a 110-
kDa transmembrane protein, which couples the hydrolysis of
ATP to the active transport of calcium ions into the SR lumen
against a concentration gradient (reviewed by Inesi, 1985).
In cardiac SR, the Ca-ATPase is regulated by phospholam-
ban (PLB), which is not found in fast-twitch skeletal SR
(Kirchberger and Tada, 1976; Tada and Katz, 1982; Jor-
gensen and Jones, 1986; Voss et al., 1994). Phospholamban
is an amphipathic, 52-residue protein, with a hydrophilic (cy-
toplasmic) phosphorylation domain and a hydrophobic
(transmembrane) domain, which probably exists as a ho-
mopentamer (Wegener et al., 1986; Simmerman et al., 1986;
Fujii et al., 1987). Phosphorylation ofPLB results in a stimu-
lation of ATPase activity and calcium uptake at submicro-
molar [Ca21] (Davis et al., 1983; Tada et al., 1988). Studies
using reconstitution of the Ca-ATPase and PLB (Inui et al.,
1986), proteolytic cleavage of the cytoplasmic portion of
PLB (Kirchberger et al., 1986), and co-expression of the
Ca-ATPase and PLB in COS-1 cells (Fujii et al., 1990; Toyo-
fuku et al., 1993) and Sf21 insect cells (Autry et al., 1994)
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provide strong evidence that unphosphorylated PLB is a Ca-
ATPase inhibitor at low [Ca2"]. Evidence has been provided
that PLB's inhibitory action involves 1) interaction between
the cytoplasmic domain of PLB and sites in the phospho-
rylation domain and nucleotide-binding hinge domain of the
Ca-ATPase (Toyofuku et al., 1993), and 2) electrostatic in-
teraction between the basic (positively charged) residues of
PLB's cytoplasmic domain and negatively charged residues
in the stalk region of the Ca-ATPase (Voss et al., 1994; Tada
et al., 1989). The regulation of the Ca-ATPase by PLB shows
an electrostatic dependence consistent with a major involve-
ment of charged residues (Xu and Kirchberger, 1989; Chiesi
and Schwaller, 1989).
Extensive spectroscopic studies of the Ca-ATPase in rab-
bit skeletal SR have shown that the molecular dynamics of
the enzyme and its associated lipids are important for the
Ca-ATPase mechanism (Thomas and Mahaney, 1993;
Thomas and Karon, 1994). For example, decreased ATPase
activity results from perturbations that decrease microsecond
protein rotational motion detected by saturation transfer elec-
tron paramagnetic resonance (ST-EPR) (Squier and Thomas,
1988; Squier et al., 1988a, b; Mahaney and Thomas, 1991).
Similarly, time-resolved phosphorescence anisotropy (TPA)
measurements show a strong correlation between conditions
that inhibit (or increase) Ca-ATPase activity and those that
promote protein association (dissociation), including some
perturbations that have negligible effects on lipid fluidity
(Birmachu and Thomas, 1990; Voss et al., 1991; Karon and
Thomas, 1993).
We have previously compared Ca-ATPase rotational dy-
namics in dog cardiac and rabbit skeletal SR (Birmachu et
al., 1993). The rotational mobility of the enzyme in cardiac
SR was much more restricted than the enzyme in skeletal SR.
Our results indicated that the decreased mobility of the
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cardiac enzyme could not be attributed to differences in lipid
composition or bilayer fluidity, but was almost certainly due
to a large fraction of the enzyme in cardiac SR associated in
large-scale aggregates. Based on previous studies correlating
changes in Ca-ATPase aggregation with changes in Ca-
ATPase mobility and activity (reviewed by Thomas and Ma-
haney, 1993), the high level of protein association and lower
Ca-ATPase activity in cardiac SR relative to skeletal SR was
attributed to the presence of PLB in the cardiac membrane
(Birmachu et al., 1993). We have investigated recently the
Ca-ATPase dynamics in cardiac SR as a function of PLB
phosphorylation and [Ca2"] (Voss et al., 1994). This work
showed that the cardiac Ca-ATPase is highly aggregated in
its inhibited state, when PLB is unphosphorylated at sub-
micromolar Ca2", but stimulation of the Ca-ATPase, either
by PLB phosphorylation or micromolar [Ca2" ], correlates
with enzyme dissociation from large aggregates.
To test directly the functional and physical effects of PLB
on the Ca-ATPase, it is desirable to study the cardiac enzyme
in its native membrane in the presence and absence of PLB.
Jones and Field (1993) have reported that cardiac SR vesicles
isolated from AT-1 cardiomyocytes are essentially devoid of
PLB, whereas mouse ventricular SR vesicles contain high
levels of PLB. AT-1 cardiomyocytes are a transplantable
tumor lineage derived from transgenic mice expressing the
SV40 large T antigen (Field, 1988). Large amounts of mouse
atrial SR vesicles sufficient for direct physical study are eas-
ily isolated from these subcutaneously growing tumors.
Therefore, in the present study, we have used TPA to char-
acterize the microsecond protein rotational motion of the
Ca-ATPase in mouse ventricular SR and mouse atrial tumor
SR (obtained from AT-1 cells), to compare directly the en-
zyme mobility in these two systems, and thus to determine
directly the effects of PLB on Ca-ATPase dynamics and
protein-protein association. Because protein rotational dif-
fusion can be affected either by protein structure or by lipid
viscosity (Saffman and Delbruck, 1975), we have also used
EPR spectroscopy to measure lipid chain rotational dynamics
in the two systems. The absence of PLB in atrial SR and the
presence of PLB in ventricular SR allows for the precise
determination of the effects of PLB on the molecular dy-
namics of the cardiac Ca-ATPase of the same isoform in the
same membrane from the same species.
MATERIALS AND METHODS
Reagents and solutions
Erythrosin 5-isothiocyanate (ErITC) was obtained from Molecular Probes
Inc. (Eugene, OR) and was stored in DMF at -70°C. Glucose oxidase type
IX, catalase, glucose, and ATP were obtained from Sigma Chemical Co. (St.
Louis, MO). Calyculin A (phosphatase inhibitor) was obtained from LC
Services Corporation (Woburn, MA). Fatty acid spin labels were obtained
from Aldrich Chemical Company (Milwaukee, WI). All other reagents were
of the highest purity available. Biochemical and spectroscopic measure-
ments were carried out in a solution containing 60 mM KCl, 1 mM MgCl2,
10 mM EGTA, 2 mM CaCl2 (0.1 ,uM free Ca2") (Fabiato, 1988), 50 mM
SR Vesicle isolation
The mouse atrial tumor and ventricular SR membranes used in this study
were identical to those isolated and characterized by Jones and Field (1993).
The isolation procedure was based on Jones and Cala (1981). Briefly, atrial
tumors from two mice (approximately 20 g of tissue each) or 110 mouse
ventricles (approximately 15 g of tissue) were homogenized 3 times for 30
s in 10 mM NaHCO3 with a Polytron. SR vesicles were collected as the
membranes sedimenting at 45,000 X g. for 30 min. After extraction with
0.6 M KCl, 30 mM histidine, pH 7.0, the vesicles were pelleted by cen-
trifugation at 45,000 X gm. for 30 min and resuspended in 0.25 M sucrose,
30 mM histidine, pH 7.2. The vesicles were frozen in small aliquots and
stored at -40°C until use. Protein concentrations were determined by the
method of Lowry et al. (1951) using BSA as a standard.
SDS gels and immunoblotting
SDS-PAGE was performed according to the method of Jones et al. (1985)
using an 8% slab gel, 1.5 mm thick. The specificity of ErITC labeling of
the Ca-ATPase was confirmed using quantitative analysis of the photo-
graphic negatives of SDS gels of SR labeled with FITC. Gels were illu-
minated with a UV lamp, and photographs were taken through a 550-nm
cutoff filter, before staining the gels with Coomassie blue, as described
previously (Birmachu et al., 1993). FITC was used in the label specificity
studies in place of ErITC because FITC fluoresces much more intensely than
ErITC, allowing visualization of the label distribution in the fluorescent
photographs. ErITC is nearly identical chemically to FITC, and inhibits both
the rabbit skeletal and dog cardiac isoforms of the Ca-ATPase in a manner
similar to that of FITC (Birmachu et al., 1993), strongly suggesting that
ErITC derivatizes primarily the FITC site of the enzyme. Immunoblotting
was performed as described by Jones and Field (1993) using the Ca-ATPase
monoclonal antibody 2A7-A1 and the PLB monoclonal antibody 2D12.
Antibody-reacting bands were detected by autoradiography after incubation
with l"I-labeled protein A (Manalan and Jones, 1982), and quantified with
the use of a Bio-Rad GS-250 Molecular Imager. Autoradiography of 32P-
containing SDS gels was performed according to the method of Voss et al.
(1994).
The amount of Ca-ATPase protein in the mouse atrial tumor and ven-
tricular SR preparations was approximately 17 and 26% of the total protein,
respectively, determined from densitometry scans of the Coomassie blue-
stained SDS polyacrylamide gels. To increase the Ca-ATPase purity in the
atrial tumor SR vesicles to a level comparable with ventricular SR, the crude
atrial tumor SR vesicles were loaded onto a discontinuous (25, 35, 40, and
50%) sucrose gradient (in 20 mM MOPS, 150 mM KCI, pH 7.2) and cen-
trifuged for 10 hat 25,000 rpm in a Beckman SW-28 rotor. The vesicles that
migrated to the 35-45% sucrose interface were harvested and pelleted at
45,000 X gm. for 30 min and resuspended in 0.25 M sucrose, 30 mM
histidine, pH 7.2. The Ca-ATPase protein in the purified atrial tumor SR
vesicles comprised approximately 25% of the total protein (Fig. 1).
Quantitative immunoblotting was used in combination with SDS gel
electrophoresis to determine the relative ratio of PLB to Ca-ATPase in the
two SR preparations (Fig. 1). The two preparations contain similar amounts
of Ca-ATPase (ventricular SR/atrial tumor = 1.13). However, the ven-
tricular SR preparation contains 7 times more PLB than does the atrial tumor
SR preparation, so the PLB/Ca-ATPase ratio is 6.2 times greater in mouse
ventricular SR than in mouse atrial tumor SR.
Labeling and sample preparation
For phosphorescence experiments, the SR vesicles were labeled with ErITC,
as described previously (Birmachu and Thomas, 1990). This procedure spe-
cifically labels the Ca-ATPase in both skeletal and cardiac SR (Birmachu
et al., 1993). However, extensive studies with skeletal SR labeled at this site
with FITC show that the enzyme is otherwise unperturbed, has normal
calcium binding, and goes through the normal calcium-pumping enzymatic
cycle with less bulky substrates such as acetyl phosphate (Teruel and Inesi,
MOPS, pH 7.0, 25°C.
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1988). Therefore, the conformational and rotational dynamics of FITC-SR
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FIGURE 1 SDS gel electrophoresis and autoradiographs of immunoblots
of optically labeled mouse ventricular SR and mouse atrial tumor SR.
Samples were labeled as described in the text. Lane 1 shows Coomassie
blue-stained protein molecular weight standards. Coomassie blue-stained
bands of ErITC-labeled ventricular and atrial tumor SR are shown in lanes
2 and 3, respectively. Photographs of the fluorescent bands of FITC-labeled
ventricular and atrial tumor SR are shown in lanes 4 and 5, respectively.
Lanes 6 and 7 show immunoblots detecting the Ca-ATPase in mouse ven-
tricular and atrial tumor SR, respectively, with SERCA2-specific mono-
clonal antibody 2A7-A1. Lanes 8 and 9 show immunoblots of PLB in mouse
ventricular and atrial tumor SR, respectively, with the monoclonal antibody
2D12. PLBH and PLBL denote the pentameric and monomeric forms ofPLB,
respectively. Note the negligible presence ofPLB in atrial tumor SR in lane
9. Molecular mass standards are: phosphorylase B (97.4 kDa), BSA (66.2
kDa), ovalbumin (45 kDa), carbonic anhydrase (31 kDa), soybean trypsin
inhibitor (21.5 kDa), and lysozyme (14.4 kDa).
and ErITC are probably representative of the unlabeled protein. Labeled
samples were kept on ice and used the same day for spectroscopic
measurements.
The stoichiometry of labeling was 0.8 ± 0.1 moles of ErITC bound per
ATPase in both the atrial and ventricular SR, determined by measuring the
absorbance at 536 nm of an aliquot of ErITC-SR in the presence of 2%
deoxycholate, using e536 = 80,000 M` cm-' for the Ca-ATPase-bound
ErITC (Birmachu and Thomas, 1990) and assuming a molecular mass of 110
kDa for the Ca-ATPase. Densitometer scans of the fluorescent and Coo-
massie blue-stained SDS polyacrylamide gels (Fig. 1) showed that the probe
binds specifically to the Ca-ATPase in both the atrial and ventricular SR,
because 68 ± 3 and 65 ± 3% of the fluorescence intensity was associated
with the 110-kDa ATPase band in both atrial and ventricular SR, respec-
tively. The remaining fluorescence intensity in each sample was localized
at the top of the gel, which we determined by Western blot analysis (not
shown) was Ca-ATPase that did not enter the gel. The specificity of labeling,
therefore, was similar to that obtained for rabbit skeletal ErITC-Ca-ATPase,
where the label reacts with >90% specificity with Lys 515 in the Ca-ATPase
(Mitchinson et al., 1982; Birmachu et al., 1993), and the extent of labeling
was nearly identical in the mouse atrial tumor SR and mouse ventricular SR
preparations.
Lipid hydrocarbon chain rotational mobility was measured with stearic
acid spin labels containing the nitroxide group at either the C-5 position
(5-SASL) or the C-16 position (16-SASL). Before incorporation into SR,
these labels were diluted from a 0.1 M dimethylformamide stock solution
into ethanol (because of the greater miscibility of ethanol with water). A
sufficient amount of label was added to SR to provide a ratio of 1 label per
150 phospholipids, while keeping the final ethanol concentration in all
samples below 1%. The labeled SR was vortexed well, diluted by a factor
of 10 with experimental buffer, and pelleted in a low-speed table-top cen-
trifuge to remove any unbound label. The pellet was resuspended in the
Phospholamban phosphorylation
Before our experiments, the SR membranes were treated with type 2A pro-
tein phosphatase at room temperature for 30 min to ensure complete de-
phosphorylation of PLB (Jones and Field, 1993). PLB phosphorylation was
performed just before gel electrophoresis and TPA data collection. SR
vesicles were incubated with 40 ,ug/ml of the catalytic subunit of protein
kinase-A in a buffer containing 50 mM Tris-HCl, 0.1 mM DTT, 2 mM
MgCl2, 0.75 mM ATP containing 2-3 mCi/ml [y-32P]ATP, 50 nM phos-
phatase inhibitor calyculin A, pH 7.0, at 30°C. After a 3-min incubation, the
sample was immediately centrifuged at 100,000 X gm. for 5 min at 4°C,
and the phosphorylated SR vesicles were resuspended in ice-cold 30 mM
MOPS, 250 mM sucrose, 50 nM calyculin A, pH 7.0, and kept on ice.
Control SR was treated in the same way, except that protein kinase-A was
omitted.
The specificity of PLB phosphorylation was measured by autoradiog-
raphy of SDS gels of sample aliquots taken directly from the PLB phos-
phorylation medium and spectroscopy samples (Voss et al., 1994). Fig. 2
indicates that most of the phosphorylation was localized to the PLB protein.
This assignment was confirmed by comparison of the autoradiographs ofSR




FIGURE 2 Autoradiograph depicting phosphorylation of PLB by the
catalytic subunit of cAMP-dependent protein kinase. Lane 1 shows Coo-
massie blue-stained protein molecular mass standards, as defined in Fig. 1.
Lanes 2 and 3 are mouse ventricular SR, and lanes 4 and 5 are mouse atrial
SR. PLB was phosphorylated as described in Materials and Methods. The
± symbols indicate whether the membrane samples were boiled in SDS
before electrophoresis. PLBH and PLBL denote the pentameric and mono-
meric forms of PLB, respectively.
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samples analyzed before (denoted by - in Fig. 2) and after (denoted by +
in Fig. 2) boiling in SDS, which converts PLB pentamers running at -25
kDa (designated PLBH) into PLB monomers running at about 6 kDa (des-
ignated PLBL). The level of PLB phosphorylation was determined by ex-
cising regions on the gel corresponding to the exposed regions on the au-
toradiograph and placing these samples in scintillation vials for liquid
scintillation counting. Four separate measurements of PLB phosphorylation
in mouse ventricular SR resulted in an average of 0.51 ± 0.08 nmol
phosphate/mg SR protein. No PLB phosphorylation in the atrial tumor SR
vesicles was discernible above the background.
Time-resolved phosphorescence
anisotropy spectroscopy
The experimental and analytical procedures for time-resolved phosphores-
cence anisotropy (TPA) of skeletal and cardiac SR have been described in
detail previously (Birmachu and Thomas, 1990; Birmachu et al., 1993).
Before TPA data collection, oxygen was removed enzymatically from the
labeled sample (0.2 to 0.4 mg SR/ml) in a sealed 1-cm quartz cuvette with
100 ,ug/ml glucose oxidase, 15 jig/ml catalase, and 5 mg/ml glucose for
10-15 min, as described previously (Birmachu et al., 1993). The spectrom-
eter used to obtain TPA decays was described previously (Ludescher and
Thomas, 1988). The phosphorescence anisotropy (r) is given by
r(t) = I + 2GI,' (1)
where I, and Ih are the time-dependent decays of the phosphorescence
intensities observed through polarizers oriented parallel and perpendicular,
respectively, to the vertically polarized excitation pulse. G is an instrumental
correction factor determined from the apparent anisotropy of the free dye
in solution, for which the corrected anisotropy is zero. TPA decays ofErITC-
labeled Ca-ATPase were detected and signal-averaged for 20 loops, each
consisting of 2000 acquisitions of Qt) and 2000 acquisitions of 4ht). The
laser repetition rate was 100-200 Hz, so a typical experiment lasted about
10 min.
TPA decays were analyzed as reported previously (Birmachu and
Thomas, 1990), using a nonlinear least-squares fit to a sum of exponentials
plus a constant:
r(t) n
tr(0) = A(t) = Aie"'i + A., (2)
where 4, are rotational correlation times, Ai are the normalized amplitudes(r/rj), A. is the normalized residual anisotropy (rjrj), and ro is the initial
anisotropy (r(0) = r. = :r; + r ). The goodness-of-fit for the anisotropy
decays was evaluated primarily from plots of the residuals (the difference
between the measured and the calculated values), and also from x2 values.
The number of exponentials (n in Eq. 2) was increased until no further
improvement was observed. In the present study, the best fit for anisotropy
decays was consistently for n = 3. This does not necessarily imply that there
are precisely three components present. It is quite possible that either 1) there
are more than three species but signal/noise is not sufficient to resolve them,
or 2) there is a continuum of exponential components. The conclusions
of the present study would not be altered by considering these other
alternatives.
It has been shown previously (Birmachu and Thomas, 1990; Mersol et
al., 1995) that the TPA of ErITC-SR is dominated by the uniaxial rotation
of the labeled Ca-ATPase about an axis normal to the bilayer. For this model,
each different rotational diffusion coefficient should give rise to a biexpo-
nential decay component (Kinosita et al., 1984) (reviewed by Thomas,
1986), but it has been shown that a single-exponential approximation is
sufficient to describe the decay for each rotating species in ErITC-SR (Bir-
machu and Thomas, 1990; Mersol et al., 1995). As long as the probe ori-
entation relative to the protein is the same for all proteins, the mole fraction
(ft) of probes in the ith rotating species, having rotational correlation time
4 is given by
A. (Ix-A'M)
t 1-A,o ' (1-Ao)' (3)
wheref, is the fraction of probes (i.e., proteins) that are immobile on the time
scale ofthe experiment (Birmachu et al., 1993). A. is the normalized residual
anisotropy of a reference sample for whichf, = 0 and describes the extent
to which the probe's motion is restricted in angular range, due to the fixed
angles Oma. and Om, of the probe's absorption and emission transition mo-
ments relative to the membrane normal:
P2(cosOma) P2(cosOme)A000 = P2(cosO,,) (4)
where P2(x) = (3x2 - 1)/2, and Oae is the angle between the absorption and
emission transition moments (Lipari and Szabo, 1980). A.0 has been shown
to be 0.22 for ErITC-Ca-ATPase in skeletal SR (Birmachu and Thomas,
1990) and is assumed to be the same for cardiac SR (Birmachu et al., 1993).
If this value of A... is an underestimate, it would result in an underestimate
of f and an overestimate of f, (Eq. 3).
The rotational diffusion coefficient (D.) for uniaxial rotation of a cy-
lindrical membrane protein can be expressed as a function of the membrane
lipid viscosity (ij), the temperature (T), and the effective radius (a) of the
portion of the protein in the bilayer (Saffman and Delbruck, 1975):
kT 1
m4ra2h'q 4 (5)
where h is the thickness of the hydrocarbon phase of the lipid bilayer. Thus,
the rotational correlation time (inversely proportional to the diffusion co-
efficient), should be proportional to the lipid viscosity (inverse of fluidity)
and to the intramembrane cross-sectional area (na2) of the rotating protein.
This theory relating protein size and lipid fluidity to protein rotational mo-
bility is supported by previous studies on the Ca-ATPase as measured by
both ST-EPR (Squier et al., 1988a, b) and phosphorescence anisotropy (Bir-
machu and Thomas, 1990), which showed that the microsecond rotational
motions of the SR probes used in those studies (including ErITC) are domi-
nated by the uniaxial rotation of the Ca-ATPase, not by rotations within the
Ca-ATPase or by tumbling of the membrane vesicles. If there are no changes
in lipid viscosity, any PLB-dependent changes in the observed rotational
correlation times must be due to changes in the effective radius (a in Eq.
5) of the rotating protein. The only plausible source of large changes in
protein size in SR is protein association into different sized oligomers, with
the rotational correlation time (p roughly proportional to the size of the
oligomer (Birmachu and Thomas, 1990). Thus, the distribution of oligo-
meric species is given by the fractionsf (Eq. 3). The fraction of proteins
in immobile species fl, determined from the residual anisotropy A., thus
corresponds to protein aggregates so large that they undergo little or no
rotational diffusion in the 1-ms time window of the TPA experiment. Be-
cause the correlation time of a Ca-ATPase monomer or dimer is on the order
of 5-30 p,s, these immobile aggregates must contain more than 10
Ca-ATPase molecules (Birmachu and Thomas, 1990; Voss et al., 1991;
Birmachu et al., 1993).
EPR spectroscopy
EPR spectra were acquired with a Bruker ESP-300 spectrometer equipped
with a Bruker ER4201 cavity, and digitized with the spectrometer's built-in
microcomputer using Bruker OS-9-compatible ESP 1620 spectral acquisi-
tion software. Spectra were downloaded to an IBM-compatible microcom-
puter and analyzed with software developed in our laboratory by R. L. H.
Bennett. EPR spectra were obtained using 100-kHz field modulation (with
a peak-to-peak modulation amplitude of 2 Gauss), with a microwave field
intensity (Hj) of 0.14 Gauss (Squier and Thomas, 1986). Sample tempera-
ture was controlled to within 0.5°C with a Bruker ER 4111VT-1003 variable
temperature controller. Sample temperature was monitored with a Sensortek
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Bat-21 digital thermometer using an IT-21 thermocouple probe inserted into
the top of the sample capillary, such that it did not interfere with spectral
acquisition.
EPR spectra were analyzed by measuring the inner (2T1) and outer (2Tj1)
spectral splittings, which are sensitive mainly to the label's rotational am-
plitude, and the half-width at half-height of the low-field peak (AL), which
is sensitive mainly to the label's rate of motion (Fig. 3). The effective order
parameter (S) for the hydrocarbon chain mobility of 5- and 16-SASL was
evaluated from the splittings by two equivalent methods. The 5-SASL spec-
tra had well resolved extrema, such that both 2T1 and 2TIcould be measured,
allowing the use of the expression (Gaffney, 1976):
S = l'- (T + C) X 1.66 (6)T 2(T; + C)
where C = 1.4 - 0.053(2T7j - 2T1). For 16-SASL spectra, Eq. 6 is not ap-
plicable for calculating the effective order parameter. Therefore, 16-SASL
order parameters were determined by the expression (Gaffney, 1976):
S=To T; (7)
where To is the isotropic hyperfine splitting constant in the absence of aniso-
tropic effects and TL is the minimum principal value of the hyperfine con-
stant for an axially symmetric system such as a lipid bilayer. The values of
T. and Tj used in this study were 14.3 and 6.3 G, respectively, as determined
previously (Squier and Thomas, 1989). The effective lipid fluidity (T/i1) was
calculated using the order parameter (S) obtained from the 5- or 16-SASL
spectra using the following empirical expression (Squier et al., 1988a):
S = -0.42 (log-) + 0.56, (8)
where T is the absolute temperature and q is the depth-dependent bilayer
viscosity in centipoise. This fluidity parameter, along with Eq. 5, can be used
to determine whether differences in Ca-ATPase rotational mobility in atrial
versus ventricular SR are due to differences in bilayer fluidity (T/fr) or to
changes in the size (aggregation state) of the rotating proteins (Mahaney and
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FIGURE 3 Phosphorescence anisotropy decay of ErITC-labeled
Ca-ATPase in MVSR, mouse ventricular SR with PLB phosphorylation
(MVSR + P), and MASR vesicles (0.3-0.6 mg/ml at 25°C in 60 mM KCl,
1 mM MgCl2, 50 mM MOPS, pH 7.0). Overlayed on the decay curves are
the fits to the decays using Eq. 2 and the parameters given in Table 2.
RESULTS
Phosphorescence emission decay
The decay ofthe total unpolarized phosphorescence emission
intensity of mouse atrial tumor SR and mouse ventricular SR
labeled with ErITC was multiexponential (Table 1). The
emission decay from both preparations was best fit by a four-
exponential function, with no improvement in the residual or
X2 of the fit by increasing n to 5. The similarities of each
lifetime and amplitude in each system is consistent with our
finding the same specificity of labeling determined from gel
electrophoresis. Thus, differences in the anisotropy decay are
not attributed to different lifetime components or component
amplitudes.
Phosphorescence anisotropy
The TPA decays of ErITC-Ca-ATPase in the two SR prepa-
rations are shown in Fig. 3. As shown previously for the TPA
decay of ErITC-labeled Ca-ATPase (Birmachu and Thomas,
1990), the TPA decays for ErITC-mouse ventricular SR were
best fit to a three-exponential decay function (Table 2). The
Ca-ATPase in both atrial tumor and ventricular SR exhibits
rotational correlation times that are identical within experi-
mental error (Table 2). The major difference between the two
SR sources is in the normalized residual anisotropy, A.,
which is significantly higher in mouse ventricular SR
(0.784 ± 0.006) than in mouse atrial tumor SR
(0.664 ± 0.011), suggesting a greater degree of motional
restriction of the ATPase in ventricular SR. Phosphorylation
of PLB reduced the A. value of ventricular SR to 0.692 ±
0.008, a level close to that of the PLB-deficient atrial tumor
SR, consistent with a model of PLB-induced protein asso-
ciation and Ca-ATPase inhibition. In contrast, exposing
MASR to phosphorylating conditions did not affect the TPA
decay curve of this sample.
Lipid chain dynamics
To determine whether higher membrane viscosity could ac-
count for the decreased Ca-ATPase rotational mobility in
ventricular SR, we measured the lipid hydrocarbon chain
mobility in mouse ventricular SR and mouse atrial tumor SR
using stearic acid spin labels. 5-SASL was used to measure
chain dynamics near the head group region of the bilayer, and
16-SASL was used to measure chain dynamics near the cen-
tral region of the bilayer. Typical EPR spectra obtained from
each probe in mouse ventricular SR and mouse atrial tumor
SR are shown in Fig. 4. The spectra were characterized by
the outer splitting, 2T(j, inner splitting, 2T'L, the outer half-
width at half-height of the low-field peak, AL, the order pa-
rameter of the label, S, and the bilayer fluidity at the label
depth, T/fq (Table 3). Because sample limitations, each ex-
periment was performed only once, and typical errors in the
spectral parameters (estimated from Mahaney and Thomas,
1991; and Mahaney et al., 1992) are listed in the legend of
Table 3. The mobility of the lipid hydrocarbon chains in the
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TABLE I Total phosphorescence emission decay parameters for mouse ventricular and atrial tumor SR labeled
with erythrosin-5-isothiocyanate
Sample T, T2 T3 T4 Al A2 A3 A4
Atrial tumor SR
11 38 129 383 0.219 0.222 0.236 0.323
(1) (3) (9) (11) (0.007) (0.013) (0.004) (0.018)
Ventricular SR
10 31 117 385 0.289 0.184 0.214 0.313
(1) (2) (5) (3) (0.013) (0.004) (0.002) (0.011)
Phosphorescence lifetimes, Ti (in ps), were obtained from a nonlinear least-squares fit of the total (unpolarized) phosphorescence intensity decays of ErITC
attached to the Ca-ATPase. The data were fit to:
I(t) D
using n = 4, with x2 from all fits within the range of 2.40-2.67. Ti are the triplet excited state lifetimes with fractional contributions Ai (normalized to the
initial intensity). The values are averages of four experiments. Values in parentheses are the SDs.
mouse atrial tumor SR bilayer is only slightly restricted rela-
tive to that of the mouse ventricular SR bilayer, as evidenced
by the very small changes in the splittings of the 5- and
16-SASL spectra (-1 and 3% change in 2T(j and 27L, re-
spectively, for each label). These small differences in split-
tings translated into slightly larger reductions of the order
parameter (3.2 and 3.8% for the 5- and 16-SASL spectra,
respectively) and fluidity (7.5 and 5.4% for the 5- and 16-
SASL spectra, respectively) in mouse atrial tumor SR rela-
tive to mouse ventricular SR. Given the estimated limits of
error on each of the spectral parameters, these differences
may not be significant, such that there is no difference in the
lipid hydrocarbon chain mobility in the two bilayers. Nev-
ertheless, because the fluidity of the mouse atrial tumor SR
bilayer is slightly reduced relative to that of the mouse ven-
tricular SR bilayer, the increased Ca-ATPase mobility in
mouse atrial tumor SR versus mouse ventricular SR cannot
be attributed to differences in lipid fluidity.
DISCUSSION
Summary of results
We present here the first direct comparative study of the
Ca-ATPase rotational dynamics in native cardiac SR mem-
branes with and without the regulatory protein PLB, de-
signed to elucidate the underlying mechanism for the regu-
lation of the cardiac Ca-ATPase. The Ca-ATPase of mouse
ventricular SR, which contains PLB, and mouse atrial tumor
SR, which is essentially devoid of PLB, was labeled with
ErITC with similar specificity in both SR preparations. TPA
measurements showed that ventricular Ca-ATPase is less ro-
tationally mobile than the atrial Ca-ATPase. The difference
in the motional properties of the Ca-ATPases in the two SR
preparations is due primarily to differences in the amplitudes
of motion, especially the limiting anisotropy A,,, not in the
rate (1/0) of motion. Conventional EPR spectra of spin-
labeled fatty acids showed no significant difference in lipid
bilayer fluidity in the two SR preparations.
Lipid dynamics
From the theory of transmembrane protein rotational mo-
bility (Saffman and Delbriick, 1975) (Eq. 5 in the present
study), the observed differences in Ca-ATPase mobility
could be due to differences in either 1) membrane viscosity
(71 in Eq. 5), or 2) the average cross sectional area (nra2 in
Eq. 5) of the rotating units in the plane of the membrane (i.e.,
an increased state of protein association). The strong influ-
ence of SR membrane fluidity on Ca-ATPase rotational mo-
bility has been demonstrated previously (Bigelow and
Thomas, 1987; Squier et al., 1988a). Therefore, we measured
the lipid chain dynamics (Fig. 4, Table 3) to determine
TABLE 2 Phosphorescence anisotropy decay parameters for mouse ventricular and atrial Ca-ATPase labeled with ErITC
Sample 40 02 43 A1 A2 A3 A. ro
Atrial tumor SR
5 50 440 0.120 0.151 0.064 0.664 0.101
(1) (2) (20) (0.016) (0.018) (0.008) (0.011) (0.004)
Ventricular SR
6.5 83 457 0.110 0.098 0.009 0.784 0.102
(2) (13) (17) (0.008) (0.011) (0.003) (0.006) (0.002)
Phosphorylated ventricular SR
5.5 53 478 0.120 0.137 0.051 0.692 0.104(1) (2) (48) (0.006) (0.020) (0.014) (0.008) (0.003)
Phosphorescence anisotropy parameters obtained from a nonlinear least squares analysis (Eq. 2 in Materials and Methods) of phosphorescence anisotropy
decays of ErITC-SR. 4)i are the rotational correlation times, and Ai are the amplitudes normalized to ro. ro is the fit value of the anisotropy extrapolated to
zero time, and A. = r,/rO is the normalized residual anisotropy. The values are averages of four experiments. Values in parentheses are the SDs. x2 from
fits with Eq. 2 in Materials and Methods of all data sets ranged from 1.43 to 1.63 for n = 3.
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FIGURE 4 EPR spectra of stearic acid spin probes at different bilayer
depths in MVSR and MASR vesicles obtained at 25°C. Samples were pre-
pared for EPR analysis as described in Materials and Methods. Spectra of
5-SASL (left) and 16-SASL (right) report lipid hydrocarbon chain fluidity
near the headgroup and central region of the bilayer, respectively. Spectra
were characterized by the outer (2T1f) and inner (2TD) spectral splittings, and
the half-width at half-height of the low field peak (AL). Baselines represent
100 Gauss.
whether any significant difference in the lipid character could
account for the difference in protein dynamics. A direct
measurement of the bilayer fluidity (T/hj) provides direct
information on the predicted effect of the lipid environment
on protein rotational mobility. The bilayer fluidity at both the
headgroup region (measured by 5-SASL) and the bilayer
center (measured by 16-SASL) were indistinguishable in
ventricular and atrial tumor SR (Table 3). Because Eq. 5
predicts the rotational diffusion coefficient (Di) of a mem-
brane protein to be directly proportional to lipid fluidity
(Th1y), the large differences in the Ca-ATPase rotational dy-
namics cannot be explained by the negligible differences in
membrane viscosity. Thus, the difference in protein dy-
namics most likely results from the differences in protein
associations.
Protein dynamics
The best fit using Eq. 2 to the TPA decays of both ventricular
and atrial ErITC-SR was achieved with n = 3, consistent
with previous results from this laboratory (Voss et al., 1994;
Birmachu et al., 1993; Birmachu and Thomas, 1990; Voss et
al., 1991). It has been shown previously that the TPA decay
of ErITC-SR reports primarily the uniaxial diffusion of the
Ca-ATPase; that is, the rotation of the protein about the mem-
brane normal (Cherry, 1978), as predicted by Eqs. 3-5 (Bir-
machu and Thomas, 1990). Each correlation time ( i, Eq. 2)
is proportional to the bilayer viscosity (iq in Eq. 5) and to the
cross sectional area of the protein in the membrane plane
(Ta2 in Eq. 5) for the ith rotating species (monomer, dimer,
etc.), and each pre-exponential factor (amplitude Ai in Eq. 2)
TABLE 3 5- and 16-SASL EPR spectral parameters at 250C
Mouse ventricular SR Mouse atrial tumor SR
5-SASL
2T' 53.9 G 54.3 G
2T1 18.0 G 17.7 G
AL 3.4G 3.1 G
S 0.63 0.65
T/rN 0.67 K/cP 0.62 K/cP
16-SASL
2T' 32.9 G 33.2 G
2T1 24.5 G 23.6 G
AL 1.5 G 1.7G
S 0.26 0.27
Tfrr 5.18 K/cP 4.90 K/cP
Conventional EPR parameters: outer splitting, 2T7; inner splitting, 2T;; outer
half-width at half-height of the low-field peak, AL; order parameter, S; bi-
layer fluidity, T/r1. Parameters 27jp 2Tj, and ALx in Gauss, are defined in Fig.
4. Order parameters are calculated from the splitting values using Eqs. 1 and
2. Bilayer fluidities (K/centipoise) are calculated from the order parameters
using Eq. 3. Values correspond to a single measurement, where typical
repetition errors are: 27j and 2T1, ±0.5 G; A 0.2 G; S, ±0.01, 5-SASL
T/q, ±0.03 K/cP; 16-SASL T/h, ±0.1. Mouse ventricular SR and mouse
atrial tumor SR correspond to mouse ventricular and atrial tumor SR,
respectively.
is proportional to the mole fraction of Ca-ATPase molecules
in that species. The primary difference between the mouse
atrial and ventricular TPA decays is in the pre-exponential
factors Ai, not in the correlation times 4i (Table 2). We have
previously discussed in detail that 02 and 03 can be assigned
to represent small and intermediate aggregation states of the
Ca-ATPase, respectively (Voss et al., 1991; Birmachu and
Thomas, 1990). The greatest ambiguity is with 41, which
could be assigned as a resolved monomer or segmental mo-
tion of the protein backbone.
The most striking difference in the phosphorescence
anisotropy decay between ventricular and atrial tumor SR
ATPases is the difference in the magnitude of A., represen-
tative of the species whose motion is too slow to observe on
the time scale of the TPA experiment. There are three pos-
sible explanations for this difference. First, the Ca-ATPase
in mouse ventricular SR could have a smaller amplitude of
wobble (cone angle 0) for rotation about axes in the mem-
brane plane, but this is unlikely, because the rotation of the
skeletal Ca-ATPase is dominated by uniaxial diffusion, not
wobble (Birmachu and Thomas, 1990). Second, the two sys-
tems could differ in the orientation of the probe relative to
the protein's axis of rotation (the membrane normal) in un-
iaxial diffusion (Eq. 4). Although this cannot be ruled out,
it is unlikely, because 1) the enzymes are of identical se-
quence, predicting identical topology, 2) a previous com-
parison of cardiac and skeletal SR (which lacks PLB) using
ST-EPR of a probe attached to a different site gives quali-
tatively the same answer in terms of overall mobility, and 3)
the difference in A. can be explained more simply without
invoking this conformational change. The third and most
likely explanation for the larger A. in ventricular SR is an
increasedfraction ofproteins rotating on a time scale slower
than the window of spectroscopic detection (in this case, 1
ms). As discussed earlier, this cannot be due to greater lipid
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FIGURE 5 Model for PLB-dependent inhibition of the Ca-ATPase.
Mouse atrial SR contains negligible amounts of PLB, so the Ca-ATPase has
increased rotational mobility and activity. Unphosphorylated PLB in MVSR
decreases Ca-ATPase rotational mobility by increasing large-scale ATPase
aggregation, with concomitant reduction of enzymatic activity. Phospho-
rylation of PLB neutralizes the peptide's cytoplasmic basic (positive)
charges, and thereby disrupts the electrostatic interaction between PLB and
one or more negative charge clusters on the cytoplasmic domain of the
enzyme. Mobilization of the Ca-ATPase relieves the inhibition. Although
only two Ca-ATPase molecules are shown, large-scale aggregation involv-
ing 10 or more Ca-ATPase molecules may be required for inhibition.
viscosity (ri in Eq. 5) in mouse ventricular SR, which would
need to be larger by a factor of 10 or more in a discrete
domain of the bilayer. This is clearly not consistent with the
V1 EPR measurements of lipid fluidity in ventricular and
atrial tumor SR (Fig. 4, Table 3). Thus, the largerA. in mouse
ventricular SR is almost certainly due to a very large increase
in the cross sectional area (-ra2 in Eq. 5) of the rotating body
in the plane of the membrane, i.e., to large-scale lateral as-
sociation of the protein.
The residual anisotropy value (A.) can be used to estimate
the fraction of Ca-ATPase that is highly immobilized in large
aggregates (Eq. 3, see Materials and Methods). We assume
that these large aggregates are completely immobilized in our
1-ms time window of observation, such that their residual
anisotropy is equal to their initial anisotropy (A. = Ao = 1).
We also assume that enzymes not in large aggregates have
the same A. (0.22) as observed in skeletal SR (Birmachu and
Thomas, 1990). Thus, the observed residual anisotropy in
mouse ventricular (A,. = 0.78), phosphorylated ventricular
(Ax. = 0.69) and atrial (Ax. = 0.66) SR, is consistent with 72,
60, and 56% of the enzyme in a highly aggregated state,
respectively. Consistent with the hypothesis that increased
Ca-ATPase association correlates with decreased enzyme ac-
tivity, both the absence of PLB in atrial SR or phosphoryl-
ation ofPLB in ventricular SR results in activation ofcalcium
transport (Jones and Field, 1993) and a decrease in the frac-
tion of large-scale Ca-ATPase aggregates. The high level of
Ca-ATPase immobilization in mouse cardiac SR that is in-
dependent of the presence of PLB can most likely be attrib-
uted to the fraction of highly aggregated Ca-ATPase in this
system (see Labeling and Sample Preparation in Materials
and Methods). The nature of the aggregation and the likely
functional manifestations warrant further study.
Relationship to other work
We have demonstrated previously that nearly half of the Ca-
ATPase in dog cardiac SR exists as large-scale aggregates,
compared with effectively no large-scale Ca-ATPase aggre-
gates in fast-twitch skeletal SR (Birmachu et al., 1993). We
have also shown that phosphorylation of PLB in dog cardiac
SR promotes Ca-ATPase disaggregation and increases Ca-
transport rates (Voss et al., 1994). In the present study, we
find that the Ca-ATPase of mouse ventricular SR is less ro-
tationally mobile than the Ca-ATPase of mouse atrial tumor
SR, because of a larger fraction of ATPases in large-scale
aggregates. The primary distinction in protein components
between mouse ventricular and atrial SR is the absence of
PLB in the latter. Thus, inhibition of Ca-ATPase activity by
PLB strongly correlates with a PLB-dependent increase in
the level of large-scale Ca-ATPase association.
CONCLUSION
We have proposed previously a model for the physical basis
of PLB inhibition of the Ca-ATPase (Voss et al., 1994; Bir-
machu et al., 1993). In this model, the basic cytoplasmic
charges of a phospholamban pentamer interact with two or
more Ca-ATPase molecules via the acidic stalk region.
Based on previous model studies of the interaction of a basic
amphipathic peptide with the Ca-ATPase (Voss et al., 1991;
Mahaney and Thomas, 1991; Mahaney et al., 1992), such
interaction would lead to a large network of immobilized
Ca-ATPase proteins, consistent with our spectroscopic re-
sults. The Ca-ATPase in atrial SR, lacking phospholamban,
would therefore display greater mobility, also consistent with
our spectroscopic results (Fig. 5). Further work will be
needed to determine the molecular mechanism whereby 1)
PLB aggregates the Ca-ATPase in a phosphorylation-
dependent manner, and 2) this aggregation inhibits the
Ca-ATPase at low calcium.
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